IP Library Granted Patent US 12,285,242
Granted Patent B2
US 12,285,242 · App. 18/391,515 · Granted Apr 29, 2025

System, device and method for safeguarding the wellbeing of patients for fluid injection

Inventors: Johannes Anton Thüring (Frechen, DE); Arthur Uber, III (Pittsburgh, PA); David Griffiths (Pittsburgh, PA); Michael McDermott (Berlin, DE); Charles Lang (Pittsburgh, PA); Linda Van Roosmalen (Gibsonia, PA); Barry Skirble (Allison Park, PA); Adam Czibur (Pittsburgh, PA); Daniel Moore (Pittsburgh, PA); Vincenzo Caruso (Ashbury, AU); Brandon Clarke (Boardman, OH)
Assignee: BAYER HEALTHCARE LLC
A61B5/0205A61B5/4848A61B5/7275A61M5/007A61M5/1723A61B5/28A61B5/296A61M2205/33G16H50/30
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,285,242
App. No.
18/391,515
Granted
Apr 29, 2025
Kind
B2
Abstract

A system and method for promoting and safeguarding the wellbeing of patients in relation to a fluid injection may obtain patient data; determine, based on the patient data, an initial risk prediction for a patient for a fluid injection to be administered to the patient, the initial risk prediction including a probability that the patient experiences at least one adverse event in response to the fluid injection; provide, to a user device, before the fluid injection is administered to the patient, the initial risk prediction; determine, after the fluid injection is started, sensor data associated with the patient; determine, based on the sensor data determined after the fluid injection is started, a current risk prediction including a probability that the patient experiences the at least one adverse event in response to the fluid injection; and provide, to the user device, the current risk prediction.

Claims (36)

1. A system comprising:

at least one processor programmed and/or configured to:

obtain patient data associated with a patient;

determine, based on the patient data, an initial risk prediction for the patient associated with a fluid injection to be administered to the patient, wherein the initial risk prediction includes a probability that the patient experiences an extravasation in response to the fluid injection;

provide, to a user device, before the fluid injection is administered to the patient, the initial risk prediction;

determine, using at least one sensor before the fluid injection, sensor data associated with the patient during a test injection administered to the patient,

determine, based on the sensor data determined during the test injection, a test prediction, wherein the test prediction includes a probability that the patient experiences the extravasation in response to the fluid injection;

provide, to the user device, the test prediction;

determine, using the at least one sensor after the fluid injection has started, the sensor data associated with the patient;

determine, based on the sensor data determined after the fluid injection is started, a current risk prediction for the patient associated with the fluid injection, wherein the current risk prediction includes a probability that the patient experiences the extravasation in response to the fluid injection; and

provide, to the user device, the current risk prediction.

2. The system of claim 1 , wherein the at least one sensor includes three sound or vibration sensors placed in three different locations on an extremity of the patient proximate an injection site for the test injection, and wherein the at least one processor is further programmed and/or configured to:

combine, through triangulation, from each sound or vibration sensor of the three sound or vibration sensors, a data stream of the sensor data to create a combined data stream; and

determine, based on the combined data stream, the test prediction.

3. The system of claim 1 , wherein the at least one sensor is further configured to:

determine, before the test injection, the sensor data, wherein determining the initial risk prediction is further based on the sensor data determined before the test injection.

4. The system of claim 1 , wherein the at least one sensor is further configured to:

determine, during the fluid injection, the sensor data, and

wherein the at least one processor is further programmed and/or configured to:

determine, based on the sensor data determined during the fluid injection, the current risk prediction; and

provide, to the user device, during the fluid injection, the current risk prediction.

5. A method comprising:

obtaining, with at least one processor, patient data associated with a patient;

determining, with the at least one processor, based on the patient data, an initial risk prediction for the patient associated with a fluid injection to be administered to the patient, wherein the initial risk prediction includes a probability that the patient experiences an extravasation in response to the fluid injection;

providing, with the at least one processor, to a user device, before the fluid injection is administered to the patient, the initial risk prediction;

determining, with at least one sensor before the fluid injection, sensor data associated with the patient during a test injection administered to the patient;

determining, with the at least one processor, based on the sensor data determined during the test injection, a test prediction, wherein the test prediction includes a probability that the patient experiences the extravasation in response to the fluid injection;

providing, with the at least one processor, to the user device, the test prediction;

determining, with the at least one sensor, after the fluid injection is started, the sensor data associated with the patient;

determining, with the at least one processor, based on the sensor data determined after the fluid injection is started, a current risk prediction for the patient associated with the fluid injection, wherein the current risk prediction includes a probability that the patient experiences the extravasation in response to the fluid injection; and

providing, with the at least one processor, to the user device, the current risk prediction.

6. The method of claim 5 , wherein the at least one sensor includes three sound or vibration sensors placed in three different locations on an extremity of the patient proximate an injection site for the test injection, and wherein the method further includes:

combining, with the at least one processor, through triangulation, from each sound or vibration sensor of the three sound or vibration sensors, a data stream of the sensor data to create a combined data stream; and

determining, with the at least one processor, based on the combined data stream, the test prediction.

7. The method of claim 5 , further comprising:

determining, with the at least one sensor, before the test injection, the sensor data, wherein determining the initial risk prediction is further based on the sensor data determined before the test injection.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 6, 2024
From: UBER, ARTHUR, III; GRIFFITHS, DAVID; MCDERMOTT, MICHAEL; LANG, CHARLES; VAN ROOSMALEN, LINDA; SKIRBLE, BARRY; CZIBUR, ADAM; MOORE, DANIEL; CARUSO, VINCENZO; CLARKE, BRANDON
To: BAYER HEALTHCARE LLC
Reel/Frame 066661/0800 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 6, 2024
From: THÜRING, JOHANNES ANTON, DR.
To: BAYER VITAL GMBH
Reel/Frame 066662/0206 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 6, 2024
From: BAYER VITAL GMBH
To: BAYER HEALTHCARE LLC
Reel/Frame 066662/0624 →
Continuity (6)
Division 17921245
Provisional Application 62706597 · Aug 27, 2020
Provisional Application 62705613 · Jul 7, 2020
Provisional Application 62704954 · Jun 4, 2020
Provisional Application 63017942 · Apr 30, 2020
Related Publication 20240115143A1 · Apr 11, 2024
References Cited (136)
US 383858A · Campbell · 1888 [cited by applicant]
US 3156236A · Williamson · 1964 [cited by applicant]
US 4610665A · Matsumoto et al. · 1986 [cited by applicant]
US 5026348A · Venegas · 1991 [cited by applicant]
US 5163928A · Hobbs et al. · 1992 [cited by applicant]
US 5334141A · Carr et al. · 1994 [cited by applicant]
US 5651776A · Appling et al. · 1997 [cited by applicant]
US 5954668A · Uber, III et al. · 1999 [cited by applicant]
US 5964703A · Goodman et al. · 1999 [cited by applicant]
US 6375624B1 · Uber, III et al. · 2002 [cited by applicant]
US 6408204B1 · Hirschman · 2002 [cited by applicant]
US 6459931B1 · Hirschman · 2002 [cited by applicant]
US 6643537B1 · Zatezalo et al. · 2003 [cited by applicant]
US 6751500B2 · Hirschman · 2004 [cited by applicant]
US 7047058B1 · Dvorsky et al. · 2006 [cited by applicant]
US 7122012B2 · Bouton et al. · 2006 [cited by applicant]
US 7553294B2 · Lazzaro et al. · 2009 [cited by applicant]
US 7563249B2 · Schriver et al. · 2009 [cited by applicant]
US 7591792B2 · Bouton · 2009 [cited by applicant]
US 7666169B2 · Cowan et al. · 2010 [cited by applicant]
US 7674244B2 · Kalafut et al. · 2010 [cited by applicant]
US 7937134B2 · Uber et al. · 2011 [cited by applicant]
US 8057406B2 · Mohiuddin · 2011 [cited by applicant]
US 8235949B2 · Hack et al. · 2012 [cited by applicant]
US 8295920B2 · Bouton et al. · 2012 [cited by applicant]
US 8403909B2 · Spohn et al. · 2013 [cited by applicant]
US 8439863B2 · Fago et al. · 2013 [cited by applicant]
US 8945051B2 · Schriver et al. · 2015 [cited by applicant]
US 9101708B2 · Small et al. · 2015 [cited by applicant]
US 9173995B1 · Tucker et al. · 2015 [cited by applicant]
US 9199033B1 · Cowan et al. · 2015 [cited by applicant]
US 9259527B2 · Spohn et al. · 2016 [cited by applicant]
US 9289550B1 · Dvorsky et al. · 2016 [cited by applicant]
US 9326686B2 · Warren et al. · 2016 [cited by applicant]
US 9333293B2 · Williams, Jr. et al. · 2016 [cited by applicant]
US 9474857B2 · Riley et al. · 2016 [cited by applicant]
US 9480791B2 · Reilly · 2016 [cited by applicant]
US 9855387B2 · Small et al. · 2018 [cited by applicant]
US 9901671B2 · Toews et al. · 2018 [cited by applicant]
US 10124110B2 · Dedig et al. · 2018 [cited by applicant]
US 10398353B2 · Addison et al. · 2019 [cited by applicant]
US 10507319B2 · Haury et al. · 2019 [cited by applicant]
US 10583256B2 · Berry et al. · 2020 [cited by applicant]
US 10933190B2 · Berry et al. · 2021 [cited by applicant]
US 11141535B2 · Uber, III et al. · 2021 [cited by applicant]
US 11478581B2 · McDermott et al. · 2022 [cited by applicant]
US 20020007116A1 · Zatezalo et al. · 2002 [cited by applicant]
US 20040171923A1 · Kalafut et al. · 2004 [cited by applicant]
US 20040253183A1 · Uber et al. · 2004 [cited by applicant]
US 20050107697A1 · Berke et al. · 2005 [cited by applicant]
US 20060079843A1 · Brooks et al. · 2006 [cited by applicant]
US 20060135940A1 · Joshi · 2006 [cited by applicant]
US 20060173360A1 · Kalafut · 2006 [cited by examiner]
US 20060211970A1 · Sciulli · 2006 [cited by applicant]
US 20070219496A1 · Kamen et al. · 2007 [cited by applicant]
US 20070276327A1 · Kalafut et al. · 2007 [cited by applicant]
US 20080015406A1 · Dlugos et al. · 2008 [cited by applicant]
US 20080147147A1 · Griffiths et al. · 2008 [cited by applicant]
US 20090112164A1 · Reilly et al. · 2009 [cited by applicant]
US 20090216192A1 · Schriver et al. · 2009 [cited by applicant]
US 20090234226A1 · Nemoto · 2009 [cited by applicant]
US 20090247961A1 · Carlyon · 2009 [cited by applicant]
US 20100114064A1 · Kalafut · 2010 [cited by examiner]
US 20100249586A1 · Cocker et al. · 2010 [cited by applicant]
US 20120089114A1 · Hemond et al. · 2012 [cited by applicant]
US 20120123257A1 · Stokes, Jr. et al. · 2012 [cited by applicant]
US 20120203177A1 · Lanier, Jr. et al. · 2012 [cited by applicant]
US 20120204997A1 · Winn et al. · 2012 [cited by applicant]
US 20130245604A1 · Kouyoumjian et al. · 2013 [cited by applicant]
US 20130261993A1 · Ruchti et al. · 2013 [cited by applicant]
US 20130274599A1 · Bouton et al. · 2013 [cited by applicant]
US 20140027009A1 · Riley et al. · 2014 [cited by applicant]
US 20140142537A1 · Gibson et al. · 2014 [cited by applicant]
US 20140276550A1 · Uram et al. · 2014 [cited by applicant]
US 20160224750A1 · Kethman et al. · 2016 [cited by applicant]
US 20160278725A1 · Van Nijnatten · 2016 [cited by applicant]
US 20160331896A1 · Nemoto et al. · 2016 [cited by applicant]
US 20160331951A1 · Sokolov et al. · 2016 [cited by applicant]
US 20170035974A1 · Berry et al. · 2017 [cited by applicant]
US 20170100534A1 · Fukikoshi et al. · 2017 [cited by applicant]
US 20170136424A1 · Schriver et al. · 2017 [cited by applicant]
US 20170143898A1 · Grosse-Wentrup et al. · 2017 [cited by applicant]
US 20170196702A1 · Agarwal et al. · 2017 [cited by applicant]
US 20170312430A1 · Schleicher et al. · 2017 [cited by applicant]
US 20180015274A1 · Haury et al. · 2018 [cited by applicant]
US 20190083699A1 · Spohn et al. · 2019 [cited by applicant]
US 20200114074A1 · Barone et al. · 2020 [cited by applicant]
US 20200129702A1 · Pedersen · 2020 [cited by applicant]
US 20200146647A1 · Uber, III et al. · 2020 [cited by applicant]
US 20200149948A1 · McDermott et al. · 2020 [cited by applicant]
US 20200179595A1 · McDermott et al. · 2020 [cited by applicant]
US 20200206414A1 · Marsh et al. · 2020 [cited by applicant]
US 20200246541A1 · Neftel et al. · 2020 [cited by applicant]
US 20200323546A1 · Skujins et al. · 2020 [cited by applicant]
US 20210146063A1 · McDermott et al. · 2021 [cited by applicant]
US 20210220556A1 · McDermott et al. · 2021 [cited by applicant]
US 20210220557A1 · Chaya et al. · 2021 [cited by applicant]
US 20220392602A1 · McDermott · 2022 [cited by applicant]
US 20220395634A1 · McDermott · 2022 [cited by applicant]
EP 1800704A1 · 2007 [cited by applicant]
EP 2692375A1 · 2014 [cited by applicant]
JP 5485885B2 · 2014 [cited by applicant]
JP 5511409B2 · 2014 [cited by applicant]
JP 5882595B2 · 2016 [cited by applicant]
JP 5897798B2 · 2016 [cited by applicant]
JP 6552258B2 · 2019 [cited by applicant]
JP 6839853B2 · 2021 [cited by applicant]
WO 2006074415A2 · 2006 [cited by applicant]
WO 2009042577A2 · 2009 [cited by applicant]
WO 2009042577A3 · 2009 [cited by applicant]
WO 2012155035A1 · 2012 [cited by applicant]
WO 2016112163A1 · 2016 [cited by applicant]
WO 2017152036A1 · 2017 [cited by applicant]
WO 2018075386A1 · 2018 [cited by applicant]
WO 2019046299A1 · 2019 [cited by applicant]
WO 2020046869A1 · 2020 [cited by applicant]
WO 2021102242A1 · 2021 [cited by applicant]
WO 2021108286A1 · 2021 [cited by applicant]
WO 2021202359A1 · 2021 [cited by applicant]
WO 2021247595A1 · 2021 [cited by applicant]
WO 2021257699A1 · 2021 [cited by applicant]
WO 2022265695A1 · 2022 [cited by applicant]
Al-Benna et al. 2013 ISRN Dermatology 2013 ID 856541 8 pages (Year: 2013). [cited by examiner]
Nouh et al. 2017 World J. Radiol. 28:339-349 (Year: 2017). [cited by examiner]
Behzadi et al, MR and CT contrast media extravasation., Medicine, 2018, 97, 9. [cited by applicant]
Brenner et al, Radiation Exposure From Medical Imaging: Time to Regulate?, JAMA, Jul. 14, 2010, vol. 304 No 2, 208-209. [cited by applicant]
Extravasation Sensor Support System LD Operation Manual, Nemoto Kyorindo Co Ltd, Sep. 13, 2012, Rev 4. [cited by applicant]
International Preliminary Report on Patentability from PCT Application No. PCT/US2021/030210, Nov. 10, 2022. [cited by applicant]
IvWatch Model 400 to aid in intravenous infiltration detection user manual Rx only, ivWatch LLC, 2019, Rev 3. [cited by applicant]
Kern et al, Multi-Sensor Activity Context Detection for Wearable Computing, 2016. [cited by applicant]
McCullough, et al., “Risk Prediction of Contrast-Induced Nephropathy”, The American Journal of Cardiology, Sep. 18, 2006, vol. 98. [cited by applicant]
Morden Peter., et al.,, The Role of Saline Flush Injection Rate in Displacement of CT Injectable Peripherally Inserted Central Catheter Tip During Power Injection of Contrast Material, AJR, Jan. 2014, 202, W13-W18. [cited by applicant]
Sachiko T. Cochran et al., Trends in Adverse Events After IV Administration of Contrast Media, Am. J. of Roentgenology, Jun. 2001, 176, 1385-1388. [cited by applicant]
Shaqdan et al, Incidence of contrast medium extravastion for CT and MRI in a large academic medical centre: A report on 502,391 injections, Clinical Radiology, Elsevier, 2014, 69, 1264-1272. [cited by applicant]
Turakhia et eal., Rationale and design of a large-scale, app-based study to identify cardiac arrhythmias using a smartwatch: The Apple Watch Study, Am Heart J, Jan. 2019, 207, 66-75. [cited by applicant]
Vinod et al, Acute compartment syndrome of hand resulting from radiograph contrast iohexol exravasation, Journal of Pharmacology and Pharmacotherapeutics, 2016, 44-7, 7-44. [cited by applicant]